Zimmer Biomet Holdings Shares Outstanding 2006-2018 | ZBH

Current and historical number of shares outstanding for Zimmer Biomet Holdings (ZBH) from 2006 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Zimmer Biomet Holdings Annual Shares Outstanding
(Millions of US $)
2017 $204
2016 $202
2015 $190
2014 $172
2013 $172
2012 $176
2011 $189
2010 $201
2009 $216
2008 $228
2007 $238
2006 $245
2005 $250
Zimmer Biomet Holdings Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $205
Q1 2018 $205
Q4 2017 $204
Q3 2017 $204
Q2 2017 $204
Q1 2017 $203
Q4 2016 $202
Q3 2016 $203
Q2 2016 $199
Q1 2016 $202
Q4 2015 $190
Q3 2015 $206
Q2 2015 $173
Q1 2015 $173
Q4 2014 $172
Q3 2014 $172
Q2 2014 $171
Q1 2014 $172
Q4 2013 $172
Q3 2013 $172
Q2 2013 $171
Q1 2013 $171
Q4 2012 $176
Q3 2012 $175
Q2 2012 $176
Q1 2012 $179
Q4 2011 $189
Q3 2011 $189
Q2 2011 $193
Q1 2011 $194
Q4 2010 $201
Q3 2010 $200
Q2 2010 $203
Q1 2010 $204
Q4 2009 $216
Q3 2009 $215
Q2 2009 $216
Q1 2009 $222
Q4 2008 $228
Q3 2008 $226
Q2 2008 $230
Q1 2008 $234
Q4 2007 $238
Q3 2007 $237
Q2 2007 $239
Q1 2007 $239
Q4 2006 $245
Q3 2006 $243
Q2 2006 $248
Q1 2006 $250
Q4 2005 $250
Q3 2005 $250
Q2 2005 $250
Q1 2005 $249
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.903B $7.824B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $123.073B 19.05
Abbott Laboratories (ABT) United States $111.627B 23.39
Stryker (SYK) United States $62.161B 24.02
Boston Scientific (BSX) United States $46.605B 24.25
Baxter (BAX) United States $37.778B 25.71
Smith & Nephew SNATS (SNN) United Kingdom $15.491B 0.00
ResMed (RMD) United States $15.453B 30.67
Bio-Rad Laboratories (BIO) United States $9.687B 62.27
Perrigo (PRGO) Ireland $9.503B 13.48
Hill-Rom Holdings (HRC) United States $6.289B 21.33
ICU Medical (ICUI) United States $6.001B 40.67
Canopy Growth (CGC) Canada $5.429B 0.00
Haemonetics (HAE) United States $5.340B 48.73
Insulet (PODD) United States $5.133B 0.00
Agios Pharmaceuticals (AGIO) United States $4.525B 0.00
Neogen (NEOG) United States $4.386B 69.89
Hutchison China MediTech (HCM) China $4.128B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.707B 0.00
NuVasive (NUVA) United States $3.433B 32.57
National Vision Holdings (EYE) United States $3.287B 72.72
Quidel (QDEL) United States $2.771B 56.77
Phibro Animal Health (PAHC) United States $2.014B 29.91
NxStage Medical (NXTM) United States $1.858B 0.00
Cardiovascular Systems (CSII) United States $1.239B 745.00
Eagle Pharmaceuticals (EGRX) United States $1.195B 35.27
VAREX IMAGING (VREX) United States $1.118B 18.26
AtriCure (ATRC) United States $1.092B 0.00
Omeros (OMER) United States $1.001B 0.00
Orthofix (OFIX) United States $1.001B 30.48
OraSure Technologies (OSUR) United States $0.995B 65.08
TG Therapeutics (TGTX) United States $0.977B 0.00
Surmodics (SRDX) United States $0.976B 117.90
Cerus (CERS) United States $0.974B 0.00
Owens & Minor (OMI) United States $0.947B 10.13
MacroGenics (MGNX) United States $0.866B 0.00
LeMaitre Vascular (LMAT) United States $0.707B 33.91
PetIQ (PETQ) United States $0.694B 23.76
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.560B 0.00
Evolus (EOLS) United States $0.530B 0.00
Lantheus Holdings (LNTH) United States $0.515B 16.01
NanoString Technologies (NSTG) United States $0.413B 0.00
Cytosorbents (CTSO) United States $0.346B 0.00
BioLife Solutions (BLFS) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.335B 21.60
Quanterix (QTRX) United States $0.315B 0.00
Surface Oncology (SURF) United States $0.275B 0.00
Rockwell Medical (RMTI) United States $0.245B 0.00
Chimerix (CMRX) United States $0.202B 0.00
Fonar (FONR) United States $0.170B 10.32
Chembio Diagnostics (CEMI) United States $0.163B 0.00
Bovie Medical (BVX) United States $0.156B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.120B 0.00
Female Health (VERU) United States $0.109B 0.00
Trinity Biotech (TRIB) Ireland $0.091B 27.13
Oramed Pharmaceuticals (ORMP) Israel $0.087B 0.00
United-Guardian (UG) United States $0.086B 18.94
Neurotrope (NTRP) United States $0.077B 0.00
InfuSystems Holdings (INFU) United States $0.076B 0.00
CAS Medical Systems (CASM) United States $0.067B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Capricor Therapeutics (CAPR) United States $0.030B 0.00
Akers Biosciences Inc (AKER) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00